Sign Up to like & get
recommendations!
0
Published in 2022 at "Drug Metabolism and Personalized Therapy"
DOI: 10.1515/dmpt-2021-0135
Abstract: Abstract Objectives This study sought to identify potential pharmacogenetic associations of selected enzymes and transporters with type 2 diabetes (T2D). In addition, pharmacogenomic profiles, concentrations of asymmetric dimethylarginine (ADMA) or kidney injury molecule-1 (KIM-1), and…
read more here.
Keywords:
enzymes transporters;
diabetes exploratory;
exploratory genetic;
type diabetes ... See more keywords